Steven Girgenti - 16 Feb 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Executive Chairman, Director
Signature
/s/ Maria Zannes, as attorney-in-fact for Steven Girgenti
Issuer symbol
BIAF
Transactions as of
16 Feb 2024
Net transactions value
+$60,000
Form type
4
Filing time
29 Mar 2024, 16:53:35 UTC
Previous filing
02 Feb 2024
Next filing
24 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Award $60,000 +39,474 +4.1% $1.52 991,758 16 Feb 2024 Direct F1
holding BIAF Common Stock 8,955 16 Feb 2024 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares, which shares will vest in full on February 16, 2027, the third anniversary of the grant date.
F2 These shares owned directly by the Cranye Girgenti Testamentary Trust (the "Trust"). The reporting person is a co-trustee of the Trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.